Ondanzetron Kabi (Ondansetron Hydrochloride Dihydrate)

Ondansetron Hydrochloride Dihydrate, the active ingredient in Ondanzetron Kabi, is a 5-HT3 receptor antagonist presented as a unknown strength/unknown form for oral use. It treats and prevents nausea and vomiting associated with chemotherapy, radiotherapy, and surgery in adult and pediatric patients.

GNH USA supplies Ondanzetron Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

Ondansetron is a selective 5‑HT3 receptor antagonist used across the nausea‑vomiting pathway to prevent treatment induced symptoms. - Chemotherapy‑induced nausea and vomiting (CINV): Reduces the frequency and severity of CINV through prevent prevent prevent. - Radiotherapy induced vom vom ​     o   t  t  t</  ",